Creative Medical net loss narrows 14.31% to $1.4 million in Q1 FY26

Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc.

CELZ

0.00
  • Creative Medical Technology Holdings posted a net loss of USD 1.4 million for quarter ended March 31, 2026, narrowing from USD 1.64 million a year earlier.
  • Operating loss improved to USD 1.46 million from USD 1.66 million, while revenue fell to no revenue from USD 3,000.
  • Research and development expense dropped 27% to USD 541,658, while selling, general and administrative expense was little changed at USD 888,640.
  • Other income rose to USD 55,436 from USD 22,381 on higher short-term investment balances; cash and US Treasuries totaled USD 5.72 million at quarter-end versus USD 7.21 million at Dec. 31, 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Creative Medical Technology Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-002893), on May 08, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.